Author

M. O. Pohl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:non-human primate· 1 Approach:statistical model· 1

Frequent Co-Authors

I. Glas· 3 shared S. Stertz· 3 shared B. G. Hale· 2 shared I. Busnadiego· 2 shared A. Caflisch· 1 shared A. Hunziker· 1 shared A. Nenes· 1 shared A. Schaub· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

I. Glas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.

S. C. David, A. Schaub, C. Terrettaz, G. Motos, L. Costa, D. S. Nolan, M. Augugliaro, I. Glas, M. O. Pohl, L. K. Klein, B. Luo, N. Bluvshtein, K. Violaki, W. Hugentobler, U. K. Krieger, , T. Kohn

This study shows that respiratory commensal bacteria enhance the stability of influenza A virus in droplets and aerosols, suggesting the microbiota may influence viral transmission risks.

bioRxiv · Feb 5, 2024Microbiology

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir

M. O. Pohl, I. Busnadiego, F. Marrafino, L. Wiedmer, A. Hunziker, S. Fernbach, I. Glas, E. V. Moroz-Omori, B. G. Hale, A. Caflisch, S. Stertz

This study combines computational screening and cellular assays to identify lenvatinib and remdesivir as synergistic inhibitors of SARS-CoV-2 replication in Vero-CCL81 cells.

bioRxiv · Mar 19, 2021Microbiology

SARS-CoV-2 Variants Reveal Features Critical for Replication in Primary Human Cells

M. O. Pohl, I. Busnadiego, V. Kufner, I. Glas, U. Karakus, S. Schmutz, M. Zaheri, I. Abela, A. Trkola, M. Huber, S. Stertz, B. G. Hale

This study identifies SARS-CoV-2 variants with distinct replication abilities in human and non-human cells, highlighting cell-specific replication features.

bioRxiv · Oct 22, 2020Microbiology